Actions

Emerging strategies and options: Difference between revisions

From MalariaETC

No edit summary
No edit summary
Line 1: Line 1:
{{DISPLAYTITLE:<span style="position: absolute; clip: rect(1px 1px 1px 1px); clip: rect(1px, 1px, 1px, 1px);">{{FULLPAGENAME}}</span>}}
{{DISPLAYTITLE:<span style="position: absolute; clip: rect(1px 1px 1px 1px); clip: rect(1px, 1px, 1px, 1px);">{{FULLPAGENAME}}</span>}}
{| class="wikitable" style="widthe:90%; border-style: solid; border-width: 4px; color:black"
{| class="wikitable" style="widthe:90%; border-style: solid; border-width: 4px; color:black"
|colspan="1" style = "font-size:100%; color:blasck; background: FFFAFA"|<span style="color:navy>'''Emerging Strategies'''</span>
|colspan="1" style = "font-size:140%; color:blasck; background: FFFAFA"|<span style="color:navy>'''Emerging Strategies for RDT design'''</span>





Revision as of 09:03, 27 September 2024

Emerging Strategies for RDT design


Multiplexed detection strategies may be used in some circumstances to optimase performance for local need:

(a) Where both P.falciparum and P.vivax are highly prevalent, then tests with specificity for each species may prove valuable - P.falciparum (HRP2) and P.vivax (Pv-pLDH) may be combined with or without a pen-specific antibody. This can offer some advantages in detecting dual infection by the two species.

(b) Where HRP2 deletion are frequent, they may cause a high risk for test failure, tests multiplexed to select for Pf-pLDH and HRP2 may improve detection in these circumstances.


Back to previous page